Hypersensitivity to polyethylene glycol in adults and children: An emerging challenge

Annamaria Bianchi1, Paolo Bottau2, Elisabetta Calamelli3

  • 1UOC Pediatria, Azienda Ospedaliera San Camillo Forlanini, Circonvallazione Gianicolense 87, Roma, 00152 Italy. annamaria.bianchi9@yahoo.it.

Insights

Hypersensitivity reactions to polyethylene glycol (PEG) are an increasing concern, particularly with COVID-19 vaccines. This review highlights diagnostic challenges and proposes management strategies for patients experiencing PEG allergies.

Area of Science:

  • Immunology
  • Pharmacology
  • Allergy

Background:

  • Polyethylene glycol (PEG) is a common ingredient in pharmaceuticals, cosmetics, and food products.
  • PEG hypersensitivity is an emerging issue, linked to anaphylaxis following COVID-19 vaccination.
  • Inconsistent nomenclature and labeling complicate the identification of PEG in products.

Purpose of the Study:

  • To review reported cases of hypersensitivity reactions to PEG.
  • To propose a standardized allergy work-up protocol for suspected PEG allergy.
  • To outline management strategies for patients with PEG hypersensitivity.

Main Methods:

  • Literature review of published cases of PEG hypersensitivity.
  • Analysis of diagnostic approaches and clinical presentations.
  • Development of a proposed allergy work-up and management plan.

Main Results:

  • PEG is a frequent excipient in various medications, often unlabelled.
  • Patients may experience recurrent reactions due to unrecognized PEG exposure.
  • Diagnostic challenges include lack of standardized testing and product information.

Conclusions:

  • Accurate diagnosis of PEG hypersensitivity requires awareness and systematic investigation.
  • Standardized allergy work-up and clear product labeling are crucial for patient safety.
  • Effective management involves avoidance of PEG and appropriate therapeutic interventions.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
18
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
19
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
27
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
23
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
20
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.5K